U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07192263) titled 'Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus' on Sept. 08.
Brief Summary: This Phase 3 study is designed to evaluate the efficacy and safety of IN-B00009 injection in adults with obesity or overweight without diabetes mellitus
Study Start Date: Sept. 22
Study Type: INTERVENTIONAL
Condition:
Obesity &Amp; Overweight
Intervention:
DRUG: IN-B00009
Test drug
DRUG: Placebo
Placebo drug
Recruitment Status: NOT_YET_RECRUITING
Sponsor: HK inno.N Corporation
Published by HT Digital Content Services with permission from Health Daily Digest....